Exosomes Derived from Mouse Adipose-Derived Mesenchymal Stem Cells Alleviate Benzalkonium Chloride-Induced Mouse Dry Eye Model via Inhibiting NLRP3 Inflammasome
Ophthalmic Research · 2022 · 65 (1) · 40-51
DOI: 10.1159/000519458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmic Research, online erschienen am 16.09.2021. Verfasst von Guifang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Loudi Central Hospital, Loudi, China. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Exosomes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
The objective of the study was to investigate efficacy and mechanisms of mouse adipose-derived mesenchymal stem cell-derived exosomes (mADSC-Exos) in the benzalkonium chloride (BAC)-induced mouse dry eye model.
Methods
Exosomes in the mADSC culture supernatant were isolated by ultracentrifugation. Western blotting, nanoparticle tracking analysis, and transmission electron microscopy were used to characterize mADSC-Exos. An experimental mouse model of dry eye was established by instillation of 0.2% BAC. mADSC-Exos were administered following BAC treatment. The positive control group was treated with commercial eye drops (0.1% pranoprofen). Corneal fluorescein staining, tear secretion, and tear film break-up time (BUT) were evaluated, and histologic analysis of the cornea and conjunctiva was performed by hematoxylin and eosin and periodic acid-Schiff staining. Apoptosis in the corneal epithelium was detected with the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and by Western blotting. Levels of pro-inflammatory cytokines in the cornea and conjunctiva were evaluated by flow cytometry, and mRNA and protein levels of NLR family pyrin domain-containing 3 (NLRP3) pathway components were assessed by quantitative real-time PCR and Western blotting, respectively. Results: mADSC-Exos were characterized as vesicles with a bilayer membrane. The particle size distribution peak was at 134 nm. mADSC-Exos specifically expressed cluster of differentiation (CD)9, CD63, and CD81. mADSC-Exos treatment repaired ocular surface damage. Additionally, mADSC-Exos inhibited cell apoptosis, decreased the levels of interleukin (IL)-1β, IL-6, IL-1α, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α, and increased levels of the anti-inflammatory cytokine IL-10. Meanwhile, NLRP3 inflammasome activation and upregulation of caspase-1, IL-1β, and IL-18 were reversed by mADSC-Exos. Conclusions: mADSC-Exos alleviate ocular surface inflammation, suggesting that it is a promising treatment for dry eye.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Loudi Central Hospital, Loudi, China.
- Department of Traditional Chinese Medicine, Loudi Central Hospital, Loudi, China.
- Department of Endocrine, Loudi Central Hospital, Loudi, China.
Zitieren
APA
Wang, G., Li, H., Long, H., Gong, X., Hu, S., & Gong, C. (2022). Exosomes Derived from Mouse Adipose-Derived Mesenchymal Stem Cells Alleviate Benzalkonium Chloride-Induced Mouse Dry Eye Model via Inhibiting NLRP3 Inflammasome. Ophthalmic Research, 65(1), 40-51. https://doi.org/10.1159/000519458
Vancouver
Wang G, Li H, Long H, Gong X, Hu S, Gong C. Exosomes Derived from Mouse Adipose-Derived Mesenchymal Stem Cells Alleviate Benzalkonium Chloride-Induced Mouse Dry Eye Model via Inhibiting NLRP3 Inflammasome. Ophthalmic Research. 2022;65(1):40-51. doi:10.1159/000519458
BibTeX
@article{Wang2022,
author = {Wang, Guifang and Li, Honghui and Long, Hongmei and Gong, Xileyuan and Hu, Shufang and Gong, Can},
title = {Exosomes Derived from Mouse Adipose-Derived Mesenchymal Stem Cells Alleviate Benzalkonium Chloride-Induced Mouse Dry Eye Model via Inhibiting NLRP3 Inflammasome},
journal = {Ophthalmic Research},
year = {2022},
volume = {65},
number = {1},
pages = {40--51},
doi = {10.1159/000519458}
}
EUVIMED